Solitary fibrous tumor
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC
Solitary fibrous tumor | |
---|---|
Synonyms | SFT |
Pronounce | N/A |
Specialty | N/A |
Symptoms | Often asymptomatic, but can include cough, chest pain, or dyspnea |
Complications | Malignant transformation, metastasis |
Onset | Typically in adulthood |
Duration | Variable |
Types | Benign, malignant |
Causes | Unknown |
Risks | Genetic mutations, environmental factors |
Diagnosis | Histopathology, immunohistochemistry |
Differential diagnosis | Hemangiopericytoma, mesothelioma, sarcoma |
Prevention | None known |
Treatment | Surgical resection, radiation therapy, chemotherapy |
Medication | None specific |
Prognosis | Generally good for benign tumors, variable for malignant |
Frequency | Rare |
Deaths | N/A |
Solitary Fibrous Tumor (SFT) is a rare type of tumor that can occur in any part of the body but is most commonly found in the pleura, which is the thin tissue surrounding the lung. Despite its name, solitary fibrous tumors can sometimes be multiple and can vary greatly in size and behavior. They were first described in the pleura but have since been identified in numerous extrapleural sites, including the meninges, peritoneum, liver, kidney, and orbit. The behavior of solitary fibrous tumors can range from benign to highly malignant.
Etiology and Pathogenesis
The exact cause of solitary fibrous tumors is unknown. They are considered to be of mesenchymal origin, arising from the connective tissue. Genetic studies have shown that the NAB2-STAT6 gene fusion is a frequent finding in SFTs, suggesting a role in the pathogenesis of these tumors.
Clinical Presentation
The symptoms of a solitary fibrous tumor can vary widely depending on its location. Many SFTs are asymptomatic and are discovered incidentally during imaging studies for unrelated reasons. When symptoms do occur, they are often related to the tumor compressing nearby structures. For example, an SFT in the thoracic cavity might cause shortness of breath, chest pain, or cough. An SFT in the central nervous system might present with headaches or neurological deficits.
Diagnosis
The diagnosis of a solitary fibrous tumor typically involves a combination of imaging studies and histopathological examination. Imaging techniques such as CT scans or MRI can help define the size and location of the tumor. However, a definitive diagnosis requires a biopsy of the tumor tissue, followed by microscopic examination and immunohistochemical staining. SFTs are typically positive for the CD34 antigen, BCL-2, and STAT6, the latter being particularly useful in confirming the diagnosis due to its association with the NAB2-STAT6 gene fusion.
Treatment
The treatment of choice for solitary fibrous tumors is surgical resection with the aim of complete removal. The feasibility and extent of surgery depend on the tumor's size, location, and relationship to surrounding structures. In cases where complete resection is not possible or the tumor is malignant, additional treatments such as radiation therapy or chemotherapy may be considered. The role of targeted therapy for SFTs is an area of ongoing research.
Prognosis
The prognosis for individuals with solitary fibrous tumors varies depending on several factors, including the size of the tumor, its location, and whether it is benign or malignant. Benign SFTs that are completely resected generally have an excellent prognosis with a low risk of recurrence. Malignant SFTs, however, can be aggressive and may metastasize to other parts of the body, leading to a poorer prognosis.
Epidemiology
Solitary fibrous tumors are rare, with an incidence that is difficult to determine due to their occurrence throughout the body and the broad range of differential diagnoses. They can occur at any age but are most commonly diagnosed in adults.
See Also
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD